Effects of lysophosphatidic acid on melanogenesis

Chemistry and Physics of Lipids

Volumn 127, Issue 2, 2004, Pages 199-206

  Kim, Dong Seok ^a   Park, Seo Hyoung ^a   Kwon, Sun Bang ^a   Youn, Sang Woong ^a   Park, Kyoung Chan ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Lysophosphatidic acid; Melanogenesis; RSK 1; Tyrosinase

Indexed keywords

LYSOPHOSPHATIDIC ACID; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PROTEIN S6; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; CELL IMMORTALIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; MELANOGENESIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

EID: 0347284329     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2003.11.002     Document Type: Article

References (31)

1. Bentley N.J., Eisen T., Goding C.R. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell Biol. 14(12):1994;7996-8006.
2. Busca R., Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13(2):2000;60-69.
3. Busca R., Bertolotto C., Ortonne J.P., Ballotti R. inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J. Biol. Chem. 271(50):1996;31824-31830.
4. De Mesquita D.D., Zhan Q., Crossley L., Badwey J.A. p90-RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant-stimulated neutrophils. FEBS Lett. 502(3):2001;84-88.
5. Dooley T.P., Gadwood R.C., Kilgore K., Thomasco L.M. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol. 7(4):1994;188-200.
6. Fueller M., Wang de A., Tigyi G., Siess W. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate. Cell Signal. 15(4):2003;367-375.
7. Hearing V.J., Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res. 2(2):1989;75-85.
8. Hearing V.J., Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J. 5(14):1991;2902-2909.
9. Hodgkinson C.A.et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix- zipper protein. Cell. 74(2):1993;395-404.
10. Hughes A.E., Newton V.E., Liu X.Z., Read A.P. A gene for waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3P12-P14.1. Nat. Genet. 7(4):1994;509-512.
11. Karliner J.S., Honbo N., Summers K., Gray M.O., Goetzl E.J. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J. Mol. Cell Cardiol. 33(9):2001;1713-1717.
12. Khaled M.et al. Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J. Biol. Chem. 277(37):2002;33690-33697.
13. Kim D.S.et al. Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation. J. Cell Sci. 116(Pt. 9):2003;1699-1706.
14. Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4(8):2002;556-564.
15. Oka M.et al. Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J. Invest. Dermatol. 115(4):2000;699-703.
16. Piazza G.A., Ritter J.L., Baracka C.A. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216(1):1995;51-64.
17. Pyne S., Pyne N.J. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349(Pt. 2):2000;385-402.
18. Retzer M., Essler M. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light-chain and moesin phosphorylation. Cell Signal. 12(9/10):2000;645-648.
19. Shida D.et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 63(7):2003;1706-1711.
20. Spiegel S. Sphingosine 1-phosphate: a prototype of a new class of second messengers. J. Leukoc. Biol. 65(3):1999;341-344.
21. Steingrimsson E. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8(3):1994;256-263.
22. Tachibana M. Evidence to suggest that expression of mitf induces melanocyte differentiation and haploinsufficiency of mitf causes waardenburg syndrome type 2A. Pigment Cell Res. 10(1/2):1997;25-33.
23. Tachibana M. MITF: a stream flowing for pigment cells. Pigment Cell Res. 13(4):2000;230-240.
24. Tassabehji M., Newton V.E., Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8(3):1994;251-255.
25. Tigyi G., Dyer D.L., Miledi R. Lysophosphatidic acid possesses dual action in cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 91(5):1994;1908- 1912.
26. Tsuboi T., Kondoh H., Hiratsuka J., Mishima Y. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res. 11(5):1998;275-282.
27. Vogler R., Sauer B., Kim D.S., Schafer-Korting M., Kleuser B. Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J. Invest. Dermatol. 120(4):2003;693-700.
28. Wu M.et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14(3):2000;301-312.
29. Ye X., Ishii I., Kingsbury M.A., Chun J. Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim. Biophys. Acta. 1585(2/3):2002;108-113.
30. York R.D.et al. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol. Cell Biol. 20(21):2000;8069-8083.
31. York R.D.et al. RAP1 mediates sustained map kinase activation induced by nerve growth factor. Nature. 392(6676):1998;622-626.